Dental Implants: What The Science Says Vs. What The Marketing Claims

This article is for informational purposes only and is not a substitute for professional medical or dental advice. Always consult a qualified healthcare provider for treatment decisions based on your personal health history.

Dental Implants: A Research-Based Look at Failure Rates, Long-Term Health Effects, and Systemic Risks

Dental implants are marketed as the gold standard for tooth replacement, with practitioners and industry websites citing success rates of 95 to 98 percent. The reality, once you look past the marketing and into the peer-reviewed literature, is considerably more nuanced. This guide walks through what the evidence actually shows about how common implants have become in the United States, how often they fail, what peri-implantitis really affects, and what we know about systemic health associations — with full study citations and transparent notes about research funding.

Dental Implants — Mechanisms of systemic effects:

Chronic inflammation from peri-implantitis (analogous to apical periodontitis in root canals)

Titanium corrosion with particulate dissemination throughout the body

Evidence base less developed than root canal systemic research, but growing

Dental Implants — Years 1–5 (Early Period):

Heart: Post-surgical bacteremia in virtually all patients, usually clears within 15 minutes; elevated endocarditis risk in valvular heart disease patients (antibiotic prophylaxis typically required)

Lungs: Rare aspiration of instruments or debris during surgery

Organs: Impaired osseointegration and delayed healing in diabetic patients

Brain: Extremely rare case reports of brain abscess from bloodstream spread

Local: Early failures (1–3%) from osseointegration failure, surgical site infection, sinus perforation in upper jaw

Dental Implants — Years 5–10:

Peri-implantitis triggers systemic inflammation via elevated pro-inflammatory cytokines (2023 PMC review)

Low-grade systemic inflammatory state: higher circulating white blood cells and dyslipidemia (elevated total cholesterol and LDL)

Cardiovascular: elevated inflammation markers and shared risk factors with atherosclerosis; direct causation unproven

Diabetes: worse glycemic control; 2025 AO/AAP meta-analysis found diabetes doubles peri-implantitis risk (OR 1.89)

Kidney and liver inflammation markers may elevate secondary to chronic oral inflammation

Dental Implants —Years 10–20:

Titanium corrosion concerns become prominent (2024 International Journal of Implant Dentistry review)

Titanium particulates induce type I and IV hypersensitivity reactions, causing amplified corrosion, osteolysis, and increased implant failure

Titanium particles documented affecting varying organ tissues systemically

Possible associations (Kim et al., 2019): yellow nail syndrome, chronic fatigue in sensitive individuals, autoimmune activation in predisposed patients

Cardiovascular: 2023 Lu et al. meta-analysis found association between peri-implantitis and CVD, but most researchers concluded shared risk factors (inflammation, obesity, smoking) rather than causation

2022 MDPI review: no direct association between diabetes, CVD, hypertension, or osteoporosis and peri-implantitis risk; obesity shows consistent positive association

Dental Implants — Years 20+:

Data is sparse because dental implants have only recently gained popularity

Cumulative burden: 22% of patients develop peri-implantitis, 53% develop mucositis

Long-term titanium exposure effects under-researched; concerns mostly from case reports

Mechanical complications accumulate: screw loosening, crown fracture, abutment failure

Part 1: Prevalence of Dental Implants in the United States

Dental implants have grown from a niche procedure to a mainstream treatment over the past two decades. The most authoritative data comes from Elani and colleagues’ 2018 study published in the Journal of Dental Research titled “Trends in Dental Implant Use in the U.S., 1999–2016, and Projections to 2026,” which analyzed seven National Health and Nutrition Examination Surveys.

They found that dental implant prevalence among adults missing teeth grew from 0.7 percent in 1999–2000 to 5.7 percent in 2015–2016 — an eight-fold increase. The largest absolute increase occurred in adults aged 65 to 74, while the largest relative increase (approximately 1,000 percent) occurred in those aged 55 to 64.

By 2026, projections range from a conservative estimate of 5.7 percent prevalence up to 23 percent among adults with missing teeth, depending on how the adoption trend continues. Currently, approximately 3 million Americans have dental implants, with roughly 500,000 new implant patients added each year.

The American Academy of Implant Dentistry reports that over 1 million patients receive implant treatment annually, with approximately 2.5 million individual implants placed per year. The U.S. dental implant market was valued at around 2.3 billion dollars in 2023. Meanwhile, approximately 120 million Americans are missing at least one tooth and over 36 million have no teeth at all, representing a vast potential pool of future implant patients.

Part 2: Dental Implant Failure Rates Over Time

Implant failure rates depend heavily on how “failure” is defined and how long patients are followed. Industry-cited figures of 98 percent success come almost exclusively from short-term studies conducted in academic settings with ideal patient selection. Real-world practice data and long-term studies paint a different picture.

Short-term survival at one year runs approximately 97 to 98 percent when measured purely as “implant still in the mouth,” though early failures (within the first three months) account for roughly 1 to 3 percent of cases. At five years, survival rates typically run 93 to 96 percent in academic studies, dropping to around 90 to 93 percent in general practice settings.

At ten years, the Howe, Keys, and Richards 2019 systematic review in the Journal of Dentistry found survival rates of approximately 96 to 97 percent in traditional analyses, but their sensitivity meta-analysis accounting for patients lost to follow-up demonstrated a possible doubling of real-world failure risk, particularly in older age groups. The Da Silva PEARL Network study cited in that review found only 81.3 percent survival over four years when excessive bone loss was included in failure criteria.

At twenty years, the 2024 meta-analysis by Kern and colleagues published in Clinical Oral Investigations — the first systematic review ever conducted at this time horizon — found a mean implant survival rate of 92 percent in prospective studies, but this dropped to 78 percent after accounting for patients lost to follow-up.

Retrospective studies showed 88 percent survival. The researchers characterized this as “approximately 4 out of 5 implants” surviving at 20 years, significantly lower than the short-term figures commonly quoted. Beyond 25 years, data becomes extremely sparse, and long-term failure rates are largely extrapolated.

What Counts as “Failure”?

Implant research uses several different definitions of failure, which is why published success rates vary so dramatically. The loosest definition is survival, meaning the implant is simply still present in the mouth regardless of its condition.

A stricter definition requires absence of peri-implant pathology, which means no inflammation, no bone loss beyond accepted thresholds, and no symptoms. The strictest definition, “success” in the formal sense, requires the implant to meet specific criteria including less than 1.5 millimeters of bone loss in the first year and less than 0.2 millimeters per year thereafter, no pain, no mobility, and no radiographic radiolucency.

Early failures occurring within three months of placement are usually caused by excessive heating of bone during drilling, over-preparation of the surgical site, low-density bone interfering with primary stability, or inadequate osseointegration.

Late failures occurring after three months are usually infectious in origin, with peri-implantitis being the dominant cause. What’s important to understand is that an implant can be a “survival success” (still present) while simultaneously being a clinical failure riddled with peri-implantitis and progressive bone loss.

Part 3: Peri-Implantitis — The Hidden Epidemic

Peri-implantitis is the most significant long-term complication of dental implants, and its prevalence is far higher than most patients are told before the procedure. It is an inflammatory disease affecting the soft and hard tissues around a dental implant, characterized by progressive bone loss that, left untreated, leads to implant failure.

The 2022 systematic review and meta-analysis by Diaz and colleagues published in BMC Oral Health, titled “What is the prevalence of peri-implantitis?”, reviewed 57 studies and found peri-implantitis in 19.53 percent of patients and 12.53 percent of implants.

A more recent 2025 systematic review published in the Journal of Dentistry using the 2017 World Workshop criteria found higher numbers: peri-implantitis in 25 percent of patients and 18 percent of implants, along with the related condition peri-implant mucositis in 63 percent of patients and 59 percent of implants.

The 2025 Galarraga-Vinueza AO/AAP systematic review and meta-analysis published in the Journal of Periodontology found that over a 20-year period, cumulative incidence rates reached approximately 53 percent for peri-implant mucositis and 22 percent for peri-implantitis.

Translating this practically: if you get a dental implant today, there is roughly a one-in-five chance you will develop peri-implantitis at some point during its lifespan, and a better-than-even chance you will develop peri-implant mucositis. These rates climb substantially in patients who smoke, have diabetes, have a history of periodontal disease, or practice poor oral hygiene.

A particularly sobering finding comes from research cited by the American Association of Endodontists: implants in patients with a history of treated chronic periodontitis fail at a rate ten times higher than natural teeth, with 100 percent of implants surviving up to five years but then failing at a rate of 10.08 percent in the six-to-ten-year range. This reframes the comparison between root canals and implants in many cases, particularly for patients whose original tooth loss was periodontal in nature.

Part 4: Long-Term Systemic Health Effects by Time Period

Research on systemic health effects of dental implants focuses on two distinct mechanisms: chronic inflammation from peri-implantitis (analogous to the apical periodontitis concerns with root canals) and titanium corrosion with particulate dissemination throughout the body. The evidence base for both is less developed than for root canal systemic associations, but is growing rapidly.

Years 1–5 (Early Period)

In the first five years after implant placement, serious systemic issues are rare if the procedure succeeded. For the heart, post-surgical bacteremia occurs in virtually all patients but usually clears within 15 minutes. Patients with pre-existing valvular heart disease are at elevated risk for infective endocarditis, which can be fatal — these patients typically require antibiotic prophylaxis before the procedure. Lung complications are rare but include potential aspiration of instruments or debris during surgery. Diabetic patients experience impaired osseointegration and delayed healing. Brain complications are extremely rare, consisting of case reports of brain abscess from infection spreading via the bloodstream. Locally, early failures (1 to 3 percent) occur from osseointegration failure, surgical site infection, and sinus perforation when implants are placed in the upper jaw.

Years 5–10

Between five and ten years, if peri-implantitis has developed, systemic inflammation becomes a documented concern. Research published in the 2023 PMC review “Peri-implantitis and systemic inflammation: A critical update” found that peri-implantitis may trigger systemic inflammation by elevating circulating levels of pro-inflammatory cytokines. Patients with peri-implantitis show low-grade systemic inflammatory states with higher circulating white blood cells and dyslipidemia (elevated total cholesterol and LDL). Cardiovascular associations during this window include elevated inflammation markers and shared risk factor profiles with atherosclerosis, though direct causation remains unproven. Diabetic patients experience worse glycemic control, with the 2025 AO/AAP meta-analysis finding diabetes doubles peri-implantitis risk (OR 1.89). Kidney and liver inflammation markers may become elevated secondary to chronic oral inflammation.

Years 10–20

In the ten-to-twenty-year window, titanium corrosion concerns become more prominent. The 2024 narrative review published in the International Journal of Implant Dentistry titled “The systemic and local interactions related to titanium implant corrosion and hypersensitivity reactions” found that titanium particulates can induce cellular immune mediators responsible for type I and type IV hypersensitivity reactions, potentially causing amplified corrosion, osteolysis, and increased implant failure. Systemically, titanium particles have been documented affecting varying organ tissues with potentially harmful effects. The 2019 review by Kim and colleagues in the International Journal of Implant Dentistry found titanium ions and particles can deposit into surrounding tissues and disseminate to distant organs, with possible associations including yellow nail syndrome, chronic fatigue in sensitive individuals, and autoimmune activation in patients with predisposition.

Cardiovascular research during this period remains mixed. The 2023 systematic review and meta-analysis by Lu and colleagues titled “Association between Cardiovascular Diseases and Peri-Implantitis” in Reviews in Cardiovascular Medicine found an association between the two conditions, though most researchers concluded they share risk factors (inflammation, obesity, smoking) rather than establishing direct causation. The 2022 MDPI narrative review concluded that most literature finds no direct association between diabetes, cardiovascular disease, hypertension, or osteoporosis and peri-implantitis risk, though obesity shows consistent positive association with implant complications.

Years 20+

Beyond twenty years, data becomes sparse. What is documented is a cumulative burden of peri-implant disease reaching 22 percent of patients developing peri-implantitis and 53 percent developing mucositis. Long-term titanium exposure effects remain under-researched, with most concerns coming from case reports rather than cohort studies. Implant mechanical complications (screw loosening, crown fracture, abutment failure) accumulate over decades.

Documented vs. Claimed Associations

The peer-reviewed literature documents several systemic associations with peri-implantitis or titanium corrosion. Cardiovascular associations include shared risk factors with atherosclerosis, elevated systemic inflammation markers, and bacterial dissemination during active peri-implantitis — though direct causation is weaker than for periodontal disease. Endocrine associations focus on the bidirectional relationship between diabetes and peri-implantitis. Autoimmune associations exist in patients with titanium hypersensitivity, including documented type I and type IV reactions. Immunological associations include elevated inflammatory markers (CRP, IL-6, TNF-alpha) in patients with active peri-implantitis. Dermatological associations include yellow nail syndrome and skin reactions in sensitive patients.

Several claims circulate widely but lack strong peer-reviewed support. Cancer from titanium implants has been claimed but not established in large epidemiological studies. Chronic fatigue syndrome, fibromyalgia, and “titanium toxicity syndrome” are discussed in clinical settings and case reports but have limited systematic evidence. Neurological conditions including multiple sclerosis, ALS, Parkinson’s, and Alzheimer’s have been speculated about but not demonstrated in controlled research. Most broad “toxicity” claims come from holistic and biological dentistry sources rather than peer-reviewed journals.

Part 5: The Scientific Studies

Implant Prevalence and Usage

Elani HW, Starr JR, Da Silva JD, Gallucci GO published the landmark 2018 study titled “Trends in Dental Implant Use in the U.S., 1999–2016, and Projections to 2026” in the Journal of Dental Research. The study documented the eight-fold increase in implant prevalence over 17 years and projected continued growth. This study used National Health and Nutrition Examination Survey (NHANES) data, which is federally collected and represents the most rigorous national dataset available.

Implant Survival and Failure Rates

Howe MS, Keys W, Richards D published “Long-term (10-year) dental implant survival: A systematic review and sensitivity meta-analysis” in 2019 in the Journal of Dentistry, volume 84, pages 9–21. This is the most methodologically rigorous 10-year analysis, demonstrating that standard survival estimates substantially underestimate real-world failure by ignoring patients lost to follow-up. Kern JS and colleagues published “How far can we go? A 20-year meta-analysis of dental implant survival rates” in 2024 in Clinical Oral Investigations, representing the first systematic review at the 20-year time horizon. Hjalmarsson L, Gheisarifar M, Jemt T published a 2016 systematic review in the European Journal of Oral Implantology covering single implants with 10-plus year follow-up. Da Silva JD and colleagues’ PEARL Network study documented real-world outcomes in general dental practices, showing substantially lower success rates than academic research.

Peri-Implantitis Prevalence and Incidence

Diaz P and colleagues published “What is the prevalence of peri-implantitis? A systematic review and meta-analysis” in 2022 in BMC Oral Health, finding 19.53 percent patient-level prevalence across 57 studies. A 2025 systematic review in the Journal of Dentistry using 2017 World Workshop criteria found 25 percent patient-level prevalence and 18 percent implant-level prevalence. Galarraga-Vinueza ME and colleagues published a major 2025 AO/AAP systematic review and meta-analysis titled “Prevalence, incidence, systemic, behavioral, and patient-related risk factors and indicators for peri-implant diseases” in the Journal of Periodontology. This study documented 20-year cumulative incidence rates of 53 percent for mucositis and 22 percent for peri-implantitis, along with detailed risk factor analysis.

Peri-Implantitis and Systemic Health

Lu H and colleagues published “Association between Cardiovascular Diseases and Peri-Implantitis: A Systematic Review and Meta-Analysis” in 2023 in Reviews in Cardiovascular Medicine, finding an association but with heterogeneous evidence. A 2023 critical review titled “Peri-implantitis and systemic inflammation: A critical update” documented elevated inflammatory cytokines, dyslipidemia, and shared risk factors with cardiovascular disease, diabetes, and obesity. The 2023 narrative review “Systemic Diseases and Biological Dental Implant Complications” in MDPI Dentistry Journal concluded that obesity shows consistent association with implant complications while other systemic diseases show mixed evidence.

Titanium Corrosion, Toxicity, and Hypersensitivity

A 2024 narrative review published in the International Journal of Implant Dentistry titled “The systemic and local interactions related to titanium implant corrosion and hypersensitivity reactions” synthesized evidence on titanium particulate dissemination, immune responses, and systemic organ effects. Kim KT and colleagues published “General review of titanium toxicity” in 2019 in the International Journal of Implant Dentistry, documenting corrosion mechanisms, particle release into surrounding tissues, and potential systemic effects. A 2020 scoping review titled “Allergies to Titanium Dental Implants: What Do We Really Know about Them?” examined hypersensitivity reaction evidence. The Olmedo research group has published extensively on titanium particulate biodistribution in animal models.

Risk Factor Studies

A 2020 retrospective study published in PMC titled “A 10 years retrospective study of assessment of prevalence and risk factors of dental implants failures” identified smoking as the strongest risk factor (37 percent failure rate), followed by hypertension (20.8 percent), diabetes (20.3 percent), and cardiovascular disease (18.7 percent), compared with only 4.37 percent failure rate in healthy patients. Ferreira SD and colleagues’ 2006 study on Brazilian subjects established early data on peri-implantitis risk variables.

Part 6: ADA and Industry-Funded Research on Implants

The American Dental Association has a more direct funding relationship with implant research than it does with root canal research. The ADA Science and Research Institute (ADASRI) maintains the Lab of Oral and Craniofacial Innovation in Gaithersburg, Maryland, where researchers including Dr. Kevin Byrd (the Anthony R. Volpe Research Scholar) actively study peri-implantitis mechanisms. This position itself reveals an important funding tie: Volpe was the retired Vice President of Clinical Research at Colgate-Palmolive, and the research center was renamed and endowed through Colgate-Palmolive funding in 2013.

ADASRI has also received grants from the American Academy of Implant Dentistry Foundation (AAIDF), which is the dedicated funding arm of the professional body representing implant dentists. The AAIDF has funded more than 70 research projects totaling over 600,000 dollars in individual grants ranging from 2,500 to 25,000 dollars. Recent AAIDF grant recipients include ADASRI’s Dr. Byrd for research on “Single Cell Immunophenotyping of the Gingival Barrier in Peri-Implantitis,” along with researchers at UCLA, Rutgers, University of Buffalo, and other institutions.

The Journal of the American Dental Association (JADA) has published multiple major implant studies, including the 2014 PEARL Network study titled “Outcomes of implants and restorations placed in general dental practices,” which was one of the first large real-world effectiveness studies. The PEARL Network was funded through NIH/NIDCR grants similar to the funding structure of the endodontic outcomes research.

This funding landscape reveals a legitimate concern worth transparently acknowledging. Implant research is more heavily funded by industry-adjacent sources than root canal research. The three largest funding streams — the AAIDF (a professional body with a direct interest in implant adoption), the ADA Foundation’s Volpe Center (partially endowed by Colgate-Palmolive), and implant manufacturers’ research partnerships with academic institutions — all have structural incentives toward favorable findings. This doesn’t invalidate the research, but it does mean patients should read implant success rate claims with awareness that the ecosystem producing them has commercial interests that don’t exist to the same degree in most areas of medical research. The NIH-funded studies and independent European longitudinal cohorts are the most reliable counterweights to industry-funded claims, and they tend to report more sobering long-term numbers.

Part 7: Critical Caveats for Interpreting This Research

Several caveats matter for correctly interpreting implant research. First, the quoted 95 to 98 percent success rates almost universally come from short-term academic studies with carefully selected patients. Real-world practice data, long-term follow-up, and strict success criteria consistently produce lower numbers. Second, “survival” is not the same as “success” — an implant can technically survive while being surrounded by active bone loss and infection. Third, patient selection dramatically affects outcomes. Healthy non-smokers with good oral hygiene and no periodontal history have failure rates around 4 percent, while smokers with diabetes and periodontal history can have failure rates exceeding 30 percent.

Fourth, peri-implantitis, unlike peri-implant mucositis, is generally not fully reversible even with treatment. Once established, it tends to progress, which means the 20-year prevalence numbers represent an accumulating problem, not a transient one. Fifth, research funding in implant dentistry is closely tied to industry, and readers should weight findings accordingly. Sixth, as with all observational research, association does not equal causation — patients who get implants tend to be older, often smokers or former smokers, and frequently have comorbidities that independently contribute to both oral and systemic health issues.

Part 8: Implants vs. Root Canals — A Fair Comparison

For readers comparing treatment options, it’s worth making the comparison directly and fairly. Root canal treatment has approximately 85 to 90 percent success at 5 years, declining to 60 percent at 20 years, with failures typically caused by new decay, crown failure, or tooth fracture. Dental implants have approximately 95 percent success at 5 years, declining to 78 to 88 percent at 20 years in the most rigorous meta-analyses, with failures caused by peri-implantitis, osseointegration failure, or mechanical complications.

On systemic health, both procedures carry similar inflammatory concerns when they fail: failed root canals produce chronic apical periodontitis, while failed implants produce peri-implantitis. Both have been associated with cardiovascular inflammation, diabetes dysregulation, and chronic low-grade systemic inflammation. Implants add a unique concern that root canals don’t have — titanium corrosion and particulate dissemination — while root canals carry concerns implants don’t, such as missed canals and persistent infections from the original tooth.

The 2024 large-scale survival comparison study found that root canal-treated teeth showed 93.75 percent survival over 2 years compared with 91.7 percent for implants, with other meta-analyses reporting no significant long-term differences between the two options over 6-year observation periods. The honest conclusion from the literature is that neither treatment is universally superior. A tooth with a treatable endodontic problem and intact coronal structure is usually better preserved with a root canal. A tooth that is structurally compromised, cracked below the gumline, or has failed retreatment is usually better replaced with an implant. The decision should be individualized rather than guided by blanket claims from either the endodontic or implant side of the profession.

Herbs with Evidence for Supporting Dental Implant and Root Canal Outcomes

No herb prevents failure of either procedure in clinical trials, but some have documented supportive effects:

For inflammation and infection control (both procedures):

Propolis: Strongest evidence. Antimicrobial against E. faecalis and peri-implant pathogens; studied as intracanal medicament and for peri-implantitis adjunct therapy

Curcumin (turmeric): Anti-inflammatory; 2020 studies show reduced peri-implant inflammatory markers when used as adjunct mouthwash

Green tea extract (EGCG): Antibacterial against oral biofilms; some peri-implantitis research as adjunct rinse

Aloe vera: Post-surgical healing support; reduces inflammation at surgical sites

For post-surgical recovery (both procedures):

Clove oil (eugenol): Topical analgesic for gum tissue only; never apply to surgical site or implant

Chamomile: Mild anti-inflammatory rinse; soothes post-procedure tissue

Saltwater rinses: Not herbal, but well-established for reducing bacterial load

For peri-implantitis specifically:

Tea tree oil: Studied as adjunct in peri-implant mucositis treatment; reduces bacterial load but must be highly diluted

Cranberry extract (proanthocyanidins): Interferes with bacterial adhesion to implant surfaces in lab studies

Neem: Antibacterial activity against peri-implant pathogens in in-vitro studies

For systemic inflammatory support (relevant when failure has occurred):

Omega-3 fatty acids (not herbal but frequently grouped): Clinical evidence for reducing peri-implantitis progression; some studies show benefit for apical periodontitis healing

Coenzyme Q10: Weak evidence for gum tissue health

Vitamin D: Important for osseointegration and bone healing around implants

Critical warnings:

Never apply essential oils or herbs directly into a root canal site, around a healing implant, or into any open surgical wound in your mouth. Doing so may cause severe irritation, introduce bacteria, and disrupt the natural healing process, potentially leading to infection or other serious complications. Always follow your trusted dentist’s specific aftercare instructions.

Turmeric, ginger, garlic, and ginkgo all interact with blood thinners — relevant before surgery

Herbs are adjunctive only; they do not replace professional treatment of peri-implantitis or failed root canals

No herb reverses established bone loss around an implant or heals a failed root canal

The Honest Bottom line: Propolis has the most robust evidence across both procedures. Curcumin and omega-3s have growing evidence for reducing inflammatory burden. Everything else ranges from plausible to marketing-driven.

Hopeful Thoughts

Dental implants have a well-established success rate of approximately 95 percent at 5 years and 78 to 92 percent at 20 years, depending on study methodology. Peri-implantitis affects approximately 20 to 25 percent of patients over time, with cumulative 20-year incidence reaching 22 percent, meaning roughly one in five patients will experience this significant complication during their implant’s lifespan. Peri-implant mucositis is even more common, affecting over 60 percent of patients.

Systemic health associations with implants mirror many of those seen with failed root canals: cardiovascular inflammation, worsened diabetes control, and chronic low-grade inflammation when peri-implantitis is active. Titanium corrosion introduces a separate concern unique to implants, with documented hypersensitivity reactions in a subset of patients and ongoing research into longer-term organ effects. The strongest documented risk factors for implant failure are smoking, diabetes, periodontal history, and poor oral hygiene.

The most impactful things for long-term implant success are patient-level factors the research consistently identifies: not smoking, rigorous oral hygiene, controlling blood sugar if diabetic, regular professional cleanings specifically designed for implants (which require different instrumentation than natural teeth), and periodic radiographic monitoring for bone loss. As with root canals, catching peri-implantitis in its earliest stages offers the best chance of preventing progressive bone loss and implant loss.

Patients considering implants should receive honest counseling that includes the real 20-year numbers, the one-in-five risk of peri-implantitis, and the fact that implants require lifelong maintenance and monitoring — not the simpler “98 percent success rate” pitch that pervades marketing materials. Informed consent means knowing both the best-case and realistic long-term outcomes before making a decision that will be with you for decades.

Medical Disclaimer: The information in this article is provided for general educational purposes and does not constitute medical, dental, or professional advice. Always consult with a qualified healthcare provider before making any treatment decisions. Statistics and associations cited are drawn from published research and reflect population-level data, which may not apply to any individual case. Individual response to treatment varies based on overall health, bone quality, oral hygiene, smoking status, systemic diseases, and many other factors. Neither the author nor the publisher is responsible for any adverse outcomes resulting from actions taken based on this content. If you are experiencing dental pain, implant complications, or signs of peri-implantitis, seek professional care immediately.